Precision Biosciences (DTIL) Selling, General & Administrative (2018 - 2026)
Precision Biosciences (DTIL) reported Selling, General & Administrative of $6.77 million for fiscal Q2 2026 (quarter ended Jun 30, 2026), down 25.9% from $9.13 million a year earlier and down 0.5% from the prior quarter.
Precision Biosciences (DTIL) Selling, General & Administrative (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Precision Biosciences' Selling, General & Administrative came in at $28.13 million, down 21.9% year-over-year; for FY2025 (ended Dec 31, 2025), it was $32.24 million, down 8.7% from FY2024.
- Selling, General & Administrative has declined for three consecutive fiscal years, with a five-year compound annual growth rate of -2.2% (FY2020 to FY2025).
- By fiscal year, Selling, General & Administrative came in at $35.3 million in FY2024 (-9.7%), $39.09 million in FY2023 (-5.3%), $41.28 million in FY2022 (+4.1%) and $39.67 million in FY2021 (+10.0%).
- The fiscal Q2 2026 figure ranks as the lowest quarterly Selling, General & Administrative since fiscal Q2 2019.
- Year over year, Selling, General & Administrative has now declined in each of the last four quarters, with an average decline of 9.4% over the last eight quarters.
- The high point for year-over-year Selling, General & Administrative in five years was fiscal Q4 2021 (growth of 15.1%); the low point was fiscal Q2 2026 (a decline of 25.9%).
- Per Business Quant data, the three fiscal quarters before Q2 2026 came in at $6.8 million (Q1 2026), $7.23 million (Q4 2025) and $7.33 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Precision Biosciences | 166.80 Mn | -182.39 Mn | - | 6.77 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.77 Mn |
| Mar 31, 2026 | 6.80 Mn |
| Dec 31, 2025 | 7.23 Mn |
| Sep 30, 2025 | 7.33 Mn |
| Jun 30, 2025 | 9.13 Mn |
| Mar 31, 2025 | 8.55 Mn |
| Dec 31, 2024 | 9.58 Mn |
| Sep 30, 2024 | 8.77 Mn |
| Jun 30, 2024 | 8.53 Mn |
| Mar 31, 2024 | 8.43 Mn |
| Dec 31, 2023 | 8.54 Mn |
| Sep 30, 2023 | 9.63 Mn |
| Jun 30, 2023 | 9.83 Mn |
| Mar 31, 2023 | 11.09 Mn |
| Dec 31, 2022 | 10.02 Mn |
| Sep 30, 2022 | 10.28 Mn |
| Jun 30, 2022 | 10.44 Mn |
| Mar 31, 2022 | 10.68 Mn |
| Dec 31, 2021 | 10.59 Mn |
| Sep 30, 2021 | 9.64 Mn |
Precision Biosciences Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=DTIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "DTIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=DTIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();